by Clinical Neuropsychologist Online | Monday, July 20, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 20, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Monday, July 20, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 20, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Monday, July 20, 2026 | Neuroscience
Nature Neuroscience, Published online: 20 July 2026; doi:10.1038/s41593-026-02369-yYu, Zhang et al. show that repeated exposure to the psychedelic drug 25C-NBOMe in adolescent rats, but not in adult rats, reduces willingness to engaged in food resource competition in...
by Clinical Neuropsychologist Online | Sunday, July 19, 2026 | Neuropsychology (general)
Abstract Neurocognitive impairments are common in paediatric central nervous system (CNS) tumours and can relate to clinical and demographic factors. The impact of social or environmental factors, such as family psychosocial risk, is less well understood. We examined...
by Clinical Neuropsychologist Online | Sunday, July 19, 2026 | Dementia
Abstract INTRODUCTION Neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), limbic-predominant age-related TDP-43 encephalopathy (LATE), and Alzheimer’s disease (AD) are associated with TAR DNA-binding protein...
